JAMA Cardiology Author Interviews

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

Nov 15, 2023
Exploring the impact of Tafamidis on cardiac function in patients with transthyretin amyloid cardiomyopathy, including insights on early treatment benefits, drug efficacy, and echocardiography effects. Discussion on the positive impact of Tafamidis in halting disease progression and improving cardiac function. Importance of assessing left atrial function in echocardiographic data collection and future treatments for transthyretin cardiomyopathy.
Ask episode
Chapters
Transcript
Episode notes